Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT800 in Pediatric Severe Hemophilia A
NCT03947320Phase 3Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of omfiloctocog alfa in hemophilia A, sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
omfiloctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT03947320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947320.